# Analysis Progress Checklist

Use this checklist to track your progress through the clustering analysis.

---

## üéØ PRE-ANALYSIS SETUP

- [ ] Data extracted from HHIMS for January 2026
- [ ] Data exported as CSV file
- [ ] Patient IDs pseudonymized (SHA-256)
- [ ] Prescriber IDs pseudonymized
- [ ] No personally identifiable information in file
- [ ] Data saved on secure hospital computer
- [ ] Read the full CLAUDE_ANALYSIS_GUIDE.md
- [ ] Have QUICK_REFERENCE.md handy for copy-paste

---

## üìä STEP 1: DATA PREPARATION (30 min)

**Status:** ‚¨ú Not Started | ‚¨ú In Progress | ‚¨ú Complete

### Checklist:
- [ ] Started new Claude conversation
- [ ] Uploaded raw CSV file
- [ ] Used Step 1 prompt from guide
- [ ] Received encounter-level transformed data
- [ ] Verified age_months calculation looks correct
- [ ] Verified antibiotic detection working (check sample rows)
- [ ] Checked data quality report (no major issues)
- [ ] Reviewed exploratory statistics:
  - [ ] Total encounters = _______
  - [ ] Antibiotic rate = _______% 
  - [ ] Polypharmacy rate = _______%
- [ ] Saved visualizations (age distribution, antibiotic pie chart, etc.)
- [ ] Downloaded 'encounter_level_clean.csv'
- [ ] File saved securely on hospital computer

**Notes:**
_________________________________________
_________________________________________

---

## üë®‚Äç‚öïÔ∏è STEP 2: PRESCRIBER ANALYSIS (15 min)

**Status:** ‚¨ú Not Started | ‚¨ú In Progress | ‚¨ú Complete

### Checklist:
- [ ] Started new Claude conversation (or continued)
- [ ] Uploaded encounter_level_clean.csv
- [ ] Used Step 2 prompt from guide
- [ ] Received prescriber metrics:
  - [ ] Number of unique prescribers = _______
  - [ ] Mean prescriber antibiotic rate = _______%
  - [ ] Prescriber with highest volume = _______
- [ ] Reviewed prescriber distribution charts
- [ ] Verified prescriber_id values properly anonymized
- [ ] Downloaded 'encounter_level_with_prescriber.csv'
- [ ] File saved securely

**Notes:**
_________________________________________
_________________________________________

---

## üéØ STEP 3: CLUSTERING ANALYSIS (45 min)

**Status:** ‚¨ú Not Started | ‚¨ú In Progress | ‚¨ú Complete

### Checklist:
- [ ] Started fresh Claude conversation
- [ ] Uploaded encounter_level_with_prescriber.csv
- [ ] Used Step 3 prompt from guide
- [ ] Received silhouette scores for k=3 to 8
- [ ] Reviewed silhouette score plot
- [ ] Selected optimal k = _______
- [ ] Confirmed optimal k with Claude
- [ ] Received final clustering results
- [ ] Verified cluster sizes reasonable (no tiny clusters)
- [ ] Reviewed cluster profiles:
  - [ ] Cluster 0: _______ encounters, _______% antibiotics
  - [ ] Cluster 1: _______ encounters, _______% antibiotics
  - [ ] Cluster 2: _______ encounters, _______% antibiotics
  - [ ] Cluster 3: _______ encounters, _______% antibiotics
  - [ ] (add more if k>4)
- [ ] Saved PCA visualization
- [ ] Saved cluster heatmap
- [ ] Downloaded 'encounter_level_clustered.csv'
- [ ] File saved securely

**Why I chose k=___:** 
_________________________________________
_________________________________________

---

## üè∑Ô∏è STEP 4: ARCHETYPE INTERPRETATION (30 min)

**Status:** ‚¨ú Not Started | ‚¨ú In Progress | ‚¨ú Complete

### Checklist:
- [ ] Started new Claude conversation
- [ ] Uploaded encounter_level_clustered.csv
- [ ] Used Step 4 prompt from guide
- [ ] Received detailed cluster profiles
- [ ] Named archetypes:
  - [ ] Cluster 0: _______________________
  - [ ] Cluster 1: _______________________
  - [ ] Cluster 2: _______________________
  - [ ] Cluster 3: _______________________
  - [ ] (add more if needed)
- [ ] Reviewed top complaints per cluster
- [ ] Reviewed top drugs per cluster
- [ ] Received comprehensive Word report
- [ ] Checked report has all visualizations embedded
- [ ] Report is thesis-ready quality
- [ ] Downloaded and saved report securely

**Key insights:**
_________________________________________
_________________________________________
_________________________________________

---

## ‚úÖ STEP 5: VALIDATION (30 min)

**Status:** ‚¨ú Not Started | ‚¨ú In Progress | ‚¨ú Complete

### Checklist:
- [ ] Started new Claude conversation
- [ ] Uploaded encounter_level_clustered.csv
- [ ] Used Step 5 prompt from guide
- [ ] Bootstrap validation completed (100 iterations)
- [ ] Received stability metrics:
  - [ ] Overall stability score = _______
  - [ ] Lowest cluster stability = _______
  - [ ] Highest cluster stability = _______
- [ ] Reviewed stability heatmap
- [ ] Statistical tests completed
- [ ] Clusters significantly different? ‚¨ú Yes ‚¨ú No
- [ ] Downloaded validation report
- [ ] Saved securely

**Validation concerns (if any):**
_________________________________________
_________________________________________

---

## üì¶ STEP 6: FINAL DELIVERABLES (30 min)

**Status:** ‚¨ú Not Started | ‚¨ú In Progress | ‚¨ú Complete

### Checklist:
- [ ] Started new Claude conversation
- [ ] Uploaded all previous CSV files
- [ ] Used Step 6 prompt from guide
- [ ] Received Excel workbook with all sheets:
  - [ ] Cluster summary statistics
  - [ ] Full encounter data with clusters
  - [ ] Prescriber analysis
  - [ ] Top drugs per cluster
  - [ ] Validation results
- [ ] Received PowerPoint presentation
- [ ] Presentation has:
  - [ ] Study overview
  - [ ] Methods
  - [ ] Cluster profiles (visual)
  - [ ] Clinical implications
- [ ] Received summary report document
- [ ] All deliverables are professional quality
- [ ] All files downloaded and saved securely
- [ ] Made backup copies

**Final file inventory:**
- [ ] encounter_level_clean.csv
- [ ] encounter_level_with_prescriber.csv
- [ ] encounter_level_clustered.csv
- [ ] cluster_analysis_report.docx
- [ ] validation_results.xlsx
- [ ] final_deliverables.xlsx
- [ ] final_presentation.pptx
- [ ] summary_report.docx

---

## üìù NEXT STEPS FOR THESIS

- [ ] Review all outputs for accuracy
- [ ] Prepare cluster vignettes for Phase 3 interviews
- [ ] Update TDF questionnaire based on cluster insights
- [ ] Share preliminary findings with supervisors
- [ ] Prepare for expert review panel (Phase 3b)
- [ ] Plan framework development based on archetypes

---

## üìû TROUBLESHOOTING LOG

**Issue 1:**
Date: __________
Problem: _________________________________________
Solution: _________________________________________

**Issue 2:**
Date: __________
Problem: _________________________________________
Solution: _________________________________________

**Issue 3:**
Date: __________
Problem: _________________________________________
Solution: _________________________________________

---

## ‚ú® KEY NUMBERS FOR THESIS

Fill these in as you complete the analysis:

- **Sample size:** _______ encounters
- **Date range:** January 1-31, 2026
- **Patients:** _______ unique patients
- **Prescribers:** _______ unique prescribers
- **Overall antibiotic rate:** _______%
- **Polypharmacy rate:** _______%
- **Optimal number of clusters:** _______
- **Silhouette score:** _______
- **Most common archetype:** _______
- **Rarest archetype:** _______

---

## üéì THESIS WRITING NOTES

**Key findings to highlight:**
1. _________________________________________
2. _________________________________________
3. _________________________________________

**Interesting patterns discovered:**
1. _________________________________________
2. _________________________________________
3. _________________________________________

**Limitations noted:**
1. _________________________________________
2. _________________________________________
3. _________________________________________

**Implications for framework (Phase 4):**
1. _________________________________________
2. _________________________________________
3. _________________________________________

---

**COMPLETION DATE:** _______________

**READY FOR PHASE 3:** ‚¨ú Yes ‚¨ú Need revisions

**SUPERVISOR REVIEW:** ‚¨ú Scheduled ‚¨ú Completed

---

üéâ **Congratulations on completing Phase 2!** üéâ

You now have your prescribing archetypes identified and validated.
These will guide your qualitative interviews and framework development.

Good luck with the rest of your MD thesis!
